Navigation Links


impairment in Medical Technology

Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia

... periodically during therapy. Hepatic impairment Metabolism of Tasigna is mainly ... hepatic impairment. Patients with moderate renal impairment (CrCL = 20-39 mL/min) should receive a 50% ... are not recommended in patients with mild renal impairment (CrCL = 40-59 mL/min). For patients with moderate ...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

... hepatic impairment. Patients with moderate renal impairment (CrCL = 20-39 mL/min) should receive a 50% ... are not recommended in patients with mild renal impairment (CrCL = 40-59 mL/min). For patients with moderate renal impairment doses greater than 400 mg are not recommended. ...

Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD

... or inattentive symptoms that cause impairment were present before age 7 years; that some impairment from the symptoms is present in two or more ... there is clear evidence of clinically significant impairment in social, academic, or occupational functioning ...

Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets

... related to Alzheimer's called mild cognitive impairment (MCI). The researchers saw improvement on various ... for Psychiatric Research. Rates of Cognitive impairment Higher Than Anticipated As the field of ... the earliest point in the disease. Mild Cognitive impairment (MCI) is the term used to describe the ...

Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury

... the American Spinal Injury Association, or ASIA, impairment Scale. Analysis of the data by dose ... were measured using the ASIA impairment Scale, or AIS. Evaluations were completed at 0, ... cervical SCI (classified as grade A on the ASIA impairment Scale) were enrolled in the trial. The ...

Mayo Clinic Finds Exercise Can Reduce the Risk of Mild Cognitive Impairment

... on April 16. Individuals with mild cognitive impairment can function reasonably well in everyday ... Most (but not all) patients with mild cognitive impairment develop a progressive decline in their thinking ... to 89 years old. Of those, 128 had mild cognitive impairment and 740 were cognitively normal. The team ...

Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results

... ongoing Phase 2a trial for MEM 3454 in cognitive impairment associated with schizophrenia and report top-line ... a Phase 2a trial of MEM 3454 in cognitive impairment associated with schizophrenia (CIAS). The ... CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, ...

Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury

... the American Spinal Injury Association, or ASIA, impairment Scale. The ASIA impairment Scale is used to score subjects within five categories from A to E, with A being complete impairment with no sensory or motor function below the site ...

Human Genome Sciences Announces Presentation at AASLD of Results of Phase 2b Trial of Albuferon(R) for Chronic Hepatitis C

... efficacy, comparable safety and less impairment of quality of life on treatment - - Final results ... of treatment - with comparable safety and less impairment of health-related quality of life on treatment. ... safety and the potential for less impairment of quality of life and daily activity," said ...

Human Genome Sciences Announces Full Presentation of Quality-of-Life Results From Phase 2b Trial of Albuferon(R) for Hepatitis C

... associated with fewer missed work days and less impairment of quality of life on treatment than ... reported fewer missed days of work and less impairment of health-related quality of life on ... treatment group. All Albuferon groups showed less impairment of health-related quality of life based on SF-36 ...

Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference

... Neurologists Surveyed on Diagnosing and Treating Mild Cognitive impairment (MCI) Scientists at ICAD 2009 reported on how clinicians view and treat mild cognitive impairment (MCI), a research category used to define the state between normal aging ...

Neuroscience Researcher Has Positive Message for International Alzheimer's Awareness Week, July 6 - 12: 'Even Though World Economy is Declining, Alzheimer's Research is Advancing'

... that causes those neurons to stop functioning and brings about cognitive impairment and symptoms associated with Alzheimer's," says Underwood. "Knowing ... stop producing these proteins at a faster rate so their cognitive impairment occurs with greater velocity." Underwood says he is confident that a ...

New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure

... component: BENICAR HCT is not recommended in patients with severe renal impairment and is contraindicated in patients with anuria or hypersensitivity to ... other adverse reactions that have occurred in adults. Hepatic impairment Thiazides should be used with caution in patients with impaired hepatic ...

Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update

... include a charge of $1.1 million for the restructuring and related asset impairment resulting from the Company's strategic restructuring plan to discontinue ... administrative 3,084 4,183 Restructuring & asset impairment 1,056 - ----- ...

Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia

... depression, bipolar disorder, Alzheimer's disease, mild cognitive impairment and other neuropsychiatric and neurodegenerative disorders where there is ... (e.g. major depression, bipolar disorder, PTSD, mild cognitive impairment and schizophrenia) and neurological diseases (e.g. Parkinson's and ...

Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia

... R3487/MEM 3454, its lead alpha-7 nicotinic receptor agonist, in cognitive impairment associated with schizophrenia (CIAS). The Company has randomized 212 ... treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease ...

Michael J. Fox Foundation Awards $2 Million for Research on Cognitive and Mood Symptoms of Parkinson's Disease

... cognitive changes. Currently available tests for detecting cognitive impairment are either insensitive to the specific changes that occur in Parkinson's, ... then follow over time to determine the ability of MoCA to detect cognitive impairment in PD. Validation of the MoCA will provide a critical research tool needed ...

Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD

... onset of some hyperactive, impulsive or inattentive symptoms that caused impairment appears before age 7 years; that some impairment from the symptoms is present in two or more settings (eg, at school and ...

Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's

... candidate for predicting Alzheimer's in people with mild cognitive impairment (MCI). MCI is a transition stage between the cognitive changes of normal ... (BACE1) functional candidate biomarkers in subjects with mild cognitive impairment and Alzheimer's disease." (Funders: Science Foundation Ireland, ...

Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies

... falling asleep. These improvements were achieved without any next day impairment of cognition or coordination. "APD125 is a potential next generation ... events and no emerging safety findings as compared to placebo. No next day impairment of cognition or coordination was observed and there was no evidence of ...

Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting

... improvements were seen in neurologic examination using the Neurological impairment Score - Lower Limbs (NIS-LL) and quantitative sensory testing (QST) which ... the visual analog scale for pain intensity (VASPI), a modified Neuropathy impairment Score - Lower Limbs (NIS-LL) scoring system as well as total neuropathy ...

CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI

... are living longer, studies suggest that therapies such as CNIs can cause impairment of kidney function, damage to the blood vessels, and filtering capacity of ... for PML, including treatment with immunosuppressant therapies and impairment of immune function. In immunosuppressed patients, physicians should ...

Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function

... are living longer, studies suggest that therapies such as CNIs can cause impairment of kidney function, damage to the blood vessels, and filtering capacity of ... for PML, including treatment with immunosuppressant therapies and impairment of immune function. In immunosuppressed patients, physicians should ...

Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day

... top-line results for its Phase 2a trial of R3487/MEM 3454 in cognitive impairment associated with schizophrenia (CIAS) in the fourth quarter -- ... treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and ...

Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists

... the onset of which appears before age 7 years; that some impairment from the symptoms is present in two or more settings (e.g., at school and ... continue for at least six months; and that there is clinically significant impairment in social, academic or occupational functioning and the symptoms cannot be ...

New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months

... the onset of which appears before age 7 years; that some impairment from the symptoms is present in two or more settings (e.g., at school and ... continue for at least six months; and that there is clinically significant impairment in social, academic or occupational functioning and the symptoms cannot be ...

Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose

... the onset of which appears before age 7 years; that some impairment from the symptoms is present in two or more settings (e.g., at school and ... continue for at least six months; and that there is clinically significant impairment in social, academic or occupational functioning and the symptoms cannot be ...

Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates

... of patients treated with Cethrin demonstrated an improvement in their impairment level on the American Spinal Injury Association scale that was ... injuries who were treated with Cethrin showed improvement using the same impairment scale that was almost 700% greater than the full patient group treated ...

Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454

... payment upon the completion of the ongoing Phase 2a study in cognitive impairment associated with schizophrenia (CIAS). In addition, Memory Pharmaceuticals ... treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and ...

Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting

... the onset of which appears before age 7 years; that some impairment from the symptoms is present in two or more settings (e.g., at school and ... continue for at least six months; and that there is clinically significant impairment in social, academic or occupational functioning and the symptoms cannot be ...

Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at 'Working 2 Walk' in Washington, DC, April 13-15, 2008

... There was improvement using the American Spinal Injury Association (ASIA) impairment scale in combined thoracic and cervical patients approximately four times ... injuries who were treated with CETHRIN showed improvement using the same impairment scale that was almost seven times greater than the full patient group ...

Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions

... from a study of diabetic mice with the Haptoglobin 2-2 genotype that show impairment in the clearance of the Haptoglobin (Hp)-Hemoglobin (Hb) complex may ... The study also demonstrated that vitamin E supplementation prevented the impairment of reverse cholesterol transport in diabetic mice with the Hp2-2 ...

ExonHit's EHT 0202 Counters Scopolamine's Detrimental Effects on Cognition in Humans

... structurally similar, thus depressing nervous system activity. Cognitive impairment due to central cholinergic dysfunction, or scopolamine administration, is ... EEG changes have been considered as possible biomarkers for AD as the impairment acetylcholine's activity is one of the landmarks of this disease. The ...

OPKO Health and Pathogenics Announce Data Publication Demonstrating the Potential Utility of NCT in a Severe Eye Infection

... keratitis (AK), a serious eye infection that can result in vision impairment or blindness. AK, which in its ocular form most commonly infects contact ... and include a combination of prescription eye medications. Severe vision impairment or loss of the eye may occur, even if the condition is diagnosed early and ...

FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria

... range from urticaria to anaphylaxis); patients with end-stage renal impairment at less than 10 mL/min creatinine clearance or patients undergoing ... be avoided because additional reductions in alertness and additional impairment of CNS performance may occur. In clinical trials, the most common ...

Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders

... trial with LX6171, an oral drug candidate for the treatment of cognitive impairment associated with disorders such as Alzheimer's disease, schizophrenia, and ... and cognitive effects in elderly subjects with age-associated memory impairment (AAMI). "AAMI is an emerging area of clinical research and offers an ...

Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration

... the onset of which appears before age 7 years; that some impairment from the symptoms is present in two or more settings (e.g., at school and ... continue for at least six months; and that there is clinically significant impairment in social, academic or occupational functioning and the symptoms cannot be ...

New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings

... improvements as measured by the BASFI, a 1 to 10 scale (1 representing no impairment and 10 representing severe impairment), which measures physical function and impairment due to the disease and subsequent improvements as a result of treatment. ...

Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting

... the onset of which appears before age 7 years; that some impairment from the symptoms is present in two or more settings (e.g., at school and ... continue for at least six months; and that there is clinically significant impairment in social, academic or occupational functioning and the symptoms cannot be ...

Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)

... the onset of which appears before age 7 years; that some impairment from the symptoms is present in two or more settings (e.g., at school and ... continue for at least six months; and that there is clinically significant impairment in social, academic or occupational functioning and the symptoms cannot be ...
Other Contentsprognosisprognosisprognosisprognosisprognosispalsypalsyprolactinprolactinprolactinprolactinpropaneproliferationproliferationproliferationproliferationproliferationproliferationproliferationproliferationproliferationproliferation
(Date:11/26/2009)...ers, red deer have been caught in the hunters, sig... more than decorative. They are lethal weapons tha... from The University of York, UK, has been intrigu...alf a century and has become fascinated by the mec...ng collaboration with Tomas Landete-Castillejos at...
(Date:11/26/2009)...phylococcus Aureus ) and other drug-resistant bact...asma prototype devices have been developed to offe...ktails. , Two prototype devices have been develo...n (e.g. hands and feet) in hospitals and public sp...another to shoot bacteria-killing agents into infe...
(Date:11/25/2009)... Cell Death Research Laboratory in the University ... the prestigious Johnson & Johnson Focused Funding...in cell damage in Parkinson,s disease. The award, ...t of innovation and excellence in science, was ann...his month at an event at the Hyatt Regency Hotel i...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2New Media Led Effort Responds to AIDS Crisis in Black America 50086 1New Media Led Effort Responds to AIDS Crisis in Black America 50086 2New Media Led Effort Responds to AIDS Crisis in Black America 50086 3New Media Led Effort Responds to AIDS Crisis in Black America 50086 4New Media Led Effort Responds to AIDS Crisis in Black America 50086 5New Media Led Effort Responds to AIDS Crisis in Black America 50086 6Abused Kids Face Higher Cancer Risk 50083 1Abused Kids Face Higher Cancer Risk 50083 2U M study finds voice box can be preserved even with the largest cancers 50080 1U M study finds voice box can be preserved even with the largest cancers 50080 2
(Date:11/30/2009)...alif., Nov. 30 Jedi Min... is pleased to announce the Company,s first though...rchase. The game, "Think-Tac-Toe" is the first of ...ith the power of their mind and is geared towards ...t a price of $49 and can be purchased directly thr...
(Date:11/30/2009)... , Study Uses Tent To Simulate High Altitude,...ewswire-USNewswire/ -- Distance runners who live a...to improve their performance during races in areas...ts, who suffer from fatigue, improve their exercis...tude simulator? ,, That is the question being s...
(Date:11/30/2009)... Switzerland, Nov. 30 Ty...ed that its 2010 annual general meeting of shareho... 3:00 p.m. Central European time at the Park Hyatt...Switzerland. Registered shareholders as of January...te at the annual general meeting. Additionally, i...
(Date:11/30/2009)...POLIS, Nov. 30 The Eject Helmet Re...quired equipment in the Top Fuel, Funny Car, Pro S...ational Hot Rod Association (NHRA) Full Throttle D...ster and Top Alcohol Funny Car drivers in the NHRA... product that allows medical caregivers at race tr...
(Date:11/30/2009)...of time between the registration of a visual stimu...gnition of it ― between the time we see an a... minds lag behind our eyes, but by how long? And h...und us? , Some estimates say the time delay la...onds. A new study by Tel Aviv University psycholog...
Breaking Medicine News(10 mins):Health News:First Thought-Controlled Game Complete From Jedi Mind, Inc. 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:National Hot Rod Association Mandates Eject Helmet Removal System for 2010 2Health News:Now you see it, now you know you see it 2
Other TagsProsthesisPtosisPtosisOther Tagseconomic 2economic 3economic 4economic 5economic 6economic 7economic 8